BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 27213797)

  • 21. Is there a correlation between the severity of diabetic retinopathy and keratoconjunctivitis sicca?
    Nepp J; Abela C; Polzer I; Derbolav A; Wedrich A
    Cornea; 2000 Jul; 19(4):487-91. PubMed ID: 10928764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of HL036 versus Cyclosporine A in the Treatment of Naturally Occurring Canine Keratoconjunctivitis Sicca.
    Lee HB; Choi HJ; Cho SM; Kang S; Ahn HK; Song YJ; Kim YJ; Son WC
    Curr Eye Res; 2018 Jul; 43(7):889-895. PubMed ID: 29634381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of cyclosporine on conjunctival mucin in a canine keratoconjunctivitis sicca model.
    Moore CP; McHugh JB; Thorne JG; Phillips TE
    Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):653-9. PubMed ID: 11222523
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Corneal in vivo confocal scanning laser microscopy in patients with atopic keratoconjunctivitis.
    Hu Y; Matsumoto Y; Adan ES; Dogru M; Fukagawa K; Tsubota K; Fujishima H
    Ophthalmology; 2008 Nov; 115(11):2004-12. PubMed ID: 18584874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Corneal protection in contact lens users].
    Egorova GB; Mitichkina TS; Shamsudinova AR
    Vestn Oftalmol; 2014; 130(2):59-64, 66-7. PubMed ID: 24864502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conjunctival in vivo confocal scanning laser microscopy in patients with atopic keratoconjunctivitis.
    Hu Y; Adan ES; Matsumoto Y; Dogru M; Fukagawa K; Takano Y; Tsubota K; Fujishima H
    Mol Vis; 2007 Aug; 13():1379-89. PubMed ID: 17768384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of amino acids enriched tears substitutes on the cornea of patients with dysfunctional tear syndrome.
    Aragona P; Rania L; Roszkowska AM; Spinella R; Postorino E; Puzzolo D; Micali A
    Acta Ophthalmol; 2013 Sep; 91(6):e437-44. PubMed ID: 23617248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Taufon use in myopic contact lens wearers].
    Naumenko VV; Pogosian MA; Sergeev VP
    Vestn Oftalmol; 2014; 130(4):97-8, 100-1. PubMed ID: 25306731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tear osmolarity measurement using the TearLab Osmolarity System in the assessment of dry eye treatment effectiveness.
    Benelli U; Nardi M; Posarelli C; Albert TG
    Cont Lens Anterior Eye; 2010 Apr; 33(2):61-7. PubMed ID: 20153684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative clinical evaluation of tacrolimus and cyclosporine eye drops for the treatment of canine keratoconjunctivitis sicca.
    Radziejewski K; Balicki I
    Acta Vet Hung; 2016 Sep; 64(3):313-329. PubMed ID: 27653428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic value of tear films tests in type 2 diabetes.
    Rahman A; Yahya K; Ahmed T; Sharif-Ul-Hasan K
    J Pak Med Assoc; 2007 Dec; 57(12):577-81. PubMed ID: 18173037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Episcleral cyclosporine A implants for the management of unilateral keratoconjunctivitis sicca in an 8-year-old mare.
    Mackenzie CJ; Carslake HB; Robin M; Kent RJ; Malalana F
    Vet Ophthalmol; 2017 Jan; 20(1):79-83. PubMed ID: 26945681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of corneal nerve density on the response to treatment in dry eye disease.
    Kheirkhah A; Dohlman TH; Amparo F; Arnoldner MA; Jamali A; Hamrah P; Dana R
    Ophthalmology; 2015 Apr; 122(4):662-8. PubMed ID: 25542519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Corneal contact time of artificial tear solutions].
    Marquardt R; Christ T
    Klin Monbl Augenheilkd; 1986 Sep; 189(3):254-7. PubMed ID: 3784417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Measurements of corneal thickness in patients with keratoconjunctivitis sicca].
    van Bijsterveld OP; Baardman J
    Klin Monbl Augenheilkd; 1990 Sep; 197(3):240-3. PubMed ID: 2255166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tear protein profiles vs. clinical characteristics of untreated and cyclosporine-treated canine KCS.
    Fullard RJ; Kaswan RM; Bounous DI; Hirsh SG
    J Am Optom Assoc; 1995 Jul; 66(7):397-404. PubMed ID: 7560726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of the precorneal residence of an artificial tear preparation in patients with keratoconjunctivitis sicca and normal volunteer subjects using gamma scintigraphy.
    Greaves JL; Wilson CG; Galloway NR; Birmingham AT; Olejnik O
    Acta Ophthalmol (Copenh); 1991 Aug; 69(4):432-6. PubMed ID: 1750310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Simultaneous evaluation of tear turnover and corneal epithelial permeability by fluorophotometry in normal subjects and patients with keratoconjunctivitis sicca (KCS).
    Nelson JD
    Trans Am Ophthalmol Soc; 1995; 93():709-53. PubMed ID: 8719697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Tear lactoferrin in keratoconjunctivitis sicca].
    Hu FR; Wang TH; Lin LL; Ko LS
    Taiwan Yi Xue Hui Za Zhi; 1989 Apr; 88(4):422-5. PubMed ID: 2794946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of topical 0.02% tacrolimus aqueous suspension on tear production in dogs with keratoconjunctivitis sicca.
    Berdoulay A; English RV; Nadelstein B
    Vet Ophthalmol; 2005; 8(4):225-32. PubMed ID: 16008701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.